⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PALI News
Palisade Bio, Inc. Common Stock
Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108
globenewswire.com
PALI
Form 8-K
sec.gov
PALI
Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis
globenewswire.com
PALI
Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026
globenewswire.com
PALI
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
globenewswire.com
PALI
Form 8-K
sec.gov
PALI
Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease
globenewswire.com
PALI
Palisade Bio Announces Participation in Two Upcoming Investor Conferences
globenewswire.com
PALI
Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
globenewswire.com
PALI
Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board
globenewswire.com
PALI